Location History:
- Pasadena, CA (US) (2009 - 2014)
- Clarksville, MD (US) (2017 - 2022)
Company Filing History:
Years Active: 2009-2022
Title: Innovations and Contributions of Inventor Xinzhong Dong
Introduction
Xinzhong Dong is a prominent inventor based in Clarksville, MD (US), known for his significant contributions to the field of medical research. He holds a total of seven patents, showcasing his innovative approach to addressing complex health issues. His work primarily focuses on developing methods and compounds that can effectively treat various medical conditions.
Latest Patents
Among his latest patents is a method for treating chronic itch conditions by administering small molecule MrgprX4 antagonists. This invention relates to cells and methods for detecting compounds that affect G protein-coupled receptor-mediated conditions. Additionally, it includes methods for treating adverse drug reactions, autoimmune disorders, and pruritus. Another notable patent involves Tmem100 peptides and variants, which are utilized in treating or preventing diseases or conditions. This invention features compositions of Tmem100 peptides and their variants, highlighting their therapeutic potential.
Career Highlights
Xinzhong Dong has had a distinguished career, working with esteemed institutions such as The Johns Hopkins University and the California Institute of Technology. His research has significantly advanced the understanding of various medical conditions and has contributed to the development of innovative treatment methods.
Collaborations
Throughout his career, Xinzhong Dong has collaborated with notable colleagues, including David J. Anderson and Mark Zylka. These collaborations have further enriched his research and have led to impactful advancements in the field.
Conclusion
In summary, Xinzhong Dong's innovative work and numerous patents reflect his dedication to improving medical treatments and understanding complex health issues. His contributions continue to influence the field of medical research and inspire future innovations.